Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Patent Profile: Neuralstem Announces Allowance of Neural Stem Cell Application

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn -- On Monday, Neuralstem, Inc. announced that the U.S. Patent and Trademark Office allowed U.S. Application No. 10/047,352 (U.S. Patent Publication No. 2002/0064873), entitled "Stable neural stem cell lines." The '352 application, which was allowed on January 13th, is directed to a method for establishing stable neural stem cell lines and neuronal progenitor lines. The timing of the '352 application's allowance is interesting in view of the recent announcement that the FDA has approved of Geron's Investigational New Drug (IND) application for the clinical trial of that company's human embryonic stem cell (hESC)-based therapeutic candidate in patients...

Full post as published by Patent Docs on January 30, 2009 (boomark / email).